220 related articles for article (PubMed ID: 33668153)
1. MicroRNA-21 Plays Multiple Oncometabolic Roles in the Process of NAFLD-Related Hepatocellular Carcinoma via PI3K/AKT, TGF-β, and STAT3 Signaling.
Lai CY; Yeh KY; Lin CY; Hsieh YW; Lai HH; Chen JR; Hsu CC; Her GM
Cancers (Basel); 2021 Feb; 13(5):. PubMed ID: 33668153
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-216a/217-induced epithelial-mesenchymal transition targets PTEN and SMAD7 to promote drug resistance and recurrence of liver cancer.
Xia H; Ooi LL; Hui KM
Hepatology; 2013 Aug; 58(2):629-41. PubMed ID: 23471579
[TBL] [Abstract][Full Text] [Related]
3. Downregulated microRNA-130b-5p prevents lipid accumulation and insulin resistance in a murine model of nonalcoholic fatty liver disease.
Liu X; Chen S; Zhang L
Am J Physiol Endocrinol Metab; 2020 Jul; 319(1):E34-E42. PubMed ID: 32228319
[TBL] [Abstract][Full Text] [Related]
4. MXD3 Promotes Obesity and the Androgen Receptor Signaling Pathway in Gender-Disparity Hepatocarcinogenesis.
Tsai YW; Jeng KS; He MK; Hsieh YW; Lai HH; Lai CY; Huang CC; Chang CF; Huang CT; Her GM
Cells; 2021 Dec; 10(12):. PubMed ID: 34943942
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-21 Plays Multiple Oncometabolic Roles in Colitis-Associated Carcinoma and Colorectal Cancer via the PI3K/AKT, STAT3, and PDCD4/TNF-α Signaling Pathways in Zebrafish.
Lai CY; Yeh KY; Liu BF; Chang TM; Chang CH; Liao YF; Liu YW; Her GM
Cancers (Basel); 2021 Nov; 13(21):. PubMed ID: 34771727
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA deregulation in nonalcoholic steatohepatitis-associated liver carcinogenesis.
de Conti A; Ortega JF; Tryndyak V; Dreval K; Moreno FS; Rusyn I; Beland FA; Pogribny IP
Oncotarget; 2017 Oct; 8(51):88517-88528. PubMed ID: 29179453
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA expression analysis in high fat diet-induced NAFLD-NASH-HCC progression: study on C57BL/6J mice.
Tessitore A; Cicciarelli G; Del Vecchio F; Gaggiano A; Verzella D; Fischietti M; Mastroiaco V; Vetuschi A; Sferra R; Barnabei R; Capece D; Zazzeroni F; Alesse E
BMC Cancer; 2016 Jan; 16():3. PubMed ID: 26728044
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-483-5p Inhibits Hepatocellular Carcinoma Cell Proliferation, Cell Steatosis, and Fibrosis by Targeting PPARα and TIMP2.
Niture S; Gadi S; Qi Q; Gyamfi MA; Varghese RS; Rios-Colon L; Chimeh U; Vandana ; Ressom HW; Kumar D
Cancers (Basel); 2023 Mar; 15(6):. PubMed ID: 36980601
[TBL] [Abstract][Full Text] [Related]
9. Methyl helicterte ameliorates liver fibrosis by regulating miR-21-mediated ERK and TGF-β1/Smads pathways.
Huang Q; Zhang X; Bai F; Nie J; Wen S; Wei Y; Wei J; Huang R; He M; Lu Z; Lin X
Int Immunopharmacol; 2019 Jan; 66():41-51. PubMed ID: 30419452
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-101 suppresses liver fibrosis by downregulating PI3K/Akt/mTOR signaling pathway.
Lei Y; Wang QL; Shen L; Tao YY; Liu CH
Clin Res Hepatol Gastroenterol; 2019 Oct; 43(5):575-584. PubMed ID: 30857885
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-497 induced by Clonorchis sinensis enhances the TGF-β/Smad signaling pathway to promote hepatic fibrosis by targeting Smad7.
Zhou QY; Yang HM; Liu JX; Xu N; Li J; Shen LP; Zhang YZ; Koda S; Zhang BB; Yu Q; Chen JX; Zheng KY; Yan C
Parasit Vectors; 2021 Sep; 14(1):472. PubMed ID: 34521449
[TBL] [Abstract][Full Text] [Related]
12. MiR-130a-3p attenuates activation and induces apoptosis of hepatic stellate cells in nonalcoholic fibrosing steatohepatitis by directly targeting TGFBR1 and TGFBR2.
Wang Y; Du J; Niu X; Fu N; Wang R; Zhang Y; Zhao S; Sun D; Nan Y
Cell Death Dis; 2017 May; 8(5):e2792. PubMed ID: 28518142
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-30 Protects Against Carbon Tetrachloride-induced Liver Fibrosis by Attenuating Transforming Growth Factor Beta Signaling in Hepatic Stellate Cells.
Tu X; Zheng X; Li H; Cao Z; Chang H; Luan S; Zhu J; Chen J; Zang Y; Zhang J
Toxicol Sci; 2015 Jul; 146(1):157-69. PubMed ID: 25912033
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of miR-188-5p alleviates hepatic fibrosis by significantly reducing the activation and proliferation of HSCs through PTEN/PI3K/AKT pathway.
Riaz F; Chen Q; Lu K; Osoro EK; Wu L; Feng L; Zhao R; Yang L; Zhou Y; He Y; Zhu L; Du X; Sadiq M; Yang X; Li D
J Cell Mol Med; 2021 Apr; 25(8):4073-4087. PubMed ID: 33689215
[TBL] [Abstract][Full Text] [Related]
15. Impact of circulating miR-122 for histological features and hepatocellular carcinoma of nonalcoholic fatty liver disease in Japan.
Akuta N; Kawamura Y; Suzuki F; Saitoh S; Arase Y; Kunimoto H; Sorin Y; Fujiyama S; Sezaki H; Hosaka T; Kobayashi M; Suzuki Y; Kobayashi M; Ikeda K; Kumada H
Hepatol Int; 2016 Jul; 10(4):647-56. PubMed ID: 27074850
[TBL] [Abstract][Full Text] [Related]
16. Administration of Steamed and Freeze-Dried Mature Silkworm Larval Powder Prevents Hepatic Fibrosis and Hepatocellular Carcinogenesis by Blocking TGF-β/STAT3 Signaling Cascades in Rats.
Lee DY; Yun SM; Song MY; Ji SD; Son JG; Kim EH
Cells; 2020 Feb; 9(3):. PubMed ID: 32121064
[TBL] [Abstract][Full Text] [Related]
17. lncRNA GAS5 restrains CCl
Dong Z; Li S; Wang X; Si L; Ma R; Bao L; Bo A
Am J Physiol Gastrointest Liver Physiol; 2019 Apr; 316(4):G539-G550. PubMed ID: 30735452
[TBL] [Abstract][Full Text] [Related]
18. Butyrate Protects against Diet-Induced NASH and Liver Fibrosis and Suppresses Specific Non-Canonical TGF-β Signaling Pathways in Human Hepatic Stellate Cells.
Gart E; van Duyvenvoorde W; Toet K; Caspers MPM; Verschuren L; Nielsen MJ; Leeming DJ; Souto Lima E; Menke A; Hanemaaijer R; Keijer J; Salic K; Kleemann R; Morrison MC
Biomedicines; 2021 Dec; 9(12):. PubMed ID: 34944770
[TBL] [Abstract][Full Text] [Related]
19. Compound Astragalus and Salvia miltiorrhiza extract inhibits hepatocellular carcinoma progression via miR-145/miR-21 mediated Smad3 phosphorylation.
Wu C; Chen W; Fang M; Boye A; Tao X; Xu Y; Hou S; Yang Y
J Ethnopharmacol; 2019 Mar; 231():98-112. PubMed ID: 30412748
[TBL] [Abstract][Full Text] [Related]
20. microRNA-29b prevents liver fibrosis by attenuating hepatic stellate cell activation and inducing apoptosis through targeting PI3K/AKT pathway.
Wang J; Chu ES; Chen HY; Man K; Go MY; Huang XR; Lan HY; Sung JJ; Yu J
Oncotarget; 2015 Mar; 6(9):7325-38. PubMed ID: 25356754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
